RXST RxSight, Inc.
Nasdaq · SEC CIK 1111485 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $118.0K 4 sales by 4 insiders
- Filings on record
- 186 since 2021-08-02, latest 2026-09-16 16:25
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Wilterding Mark | CFO | — | $54.0K |
| Kurtz Ronald M MD | Chief Medical Off | — | $35.5K |
| Goldshleger Ilya | See remarks | — | $14.2K |
| Weinberg Eric | See remarks | — | $14.2K |
| Gaines Scott | Chief Customer Off | — | — |
| Fountain Tamara | Dir | — | — |
| Corley Jesse Anderson | Dir | — | — |
| Warner Robert Keith | Dir | — | — |
| Maniar Shweta | Dir | — | — |
| Andrews Julie | Dir | — | — |
Transactions 218
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-16 16:25 | 2026-09-15 | RXST | Weinberg Eric | See remarks | M - OptEx | $4.34 | +35.2K | 235.5K | +18% | +$152.6K |
| D | 2026-09-02 21:35 | 2026-08-31 | RXST | Kurtz Ronald M MD | Chief Medical Off | M - OptEx | — | +13.4K | 76.9K | +21% | — |
| D | 2026-09-02 21:35 | 2026-09-02 | RXST | Kurtz Ronald M MD | Chief Medical Off | S - Sale+OE | $6.96 | -5,100 | 71.8K | -7% | -$35.5K |
| D | 2026-09-02 21:35 | 2026-08-31 | RXST | Wilterding Mark | CFO | M - OptEx | — | +20.4K | 32.8K | +165% | — |
| D | 2026-09-02 21:35 | 2026-09-02 | RXST | Wilterding Mark | CFO | S - Sale+OE | $6.96 | -7,765 | 25.0K | -24% | -$54.0K |
| D | 2026-09-02 21:34 | 2026-08-31 | RXST | Goldshleger Ilya | COO | M - OptEx | — | +5,370 | 83.5K | +7% | — |
| D | 2026-09-02 21:34 | 2026-09-02 | RXST | Goldshleger Ilya | COO | S - Sale+OE | $6.96 | -2,041 | 81.5K | -2% | -$14.2K |
| D | 2026-09-02 21:33 | 2026-08-31 | RXST | Weinberg Eric | See remarks | M - OptEx | — | +5,370 | 202.4K | +3% | — |
| D | 2026-09-02 21:33 | 2026-09-02 | RXST | Weinberg Eric | See remarks | S - Sale+OE | $6.96 | -2,041 | 200.3K | -1% | -$14.2K |
| 2026-06-18 16:10 | 2026-06-17 | RXST | Warner Robert Keith | Dir | A - Grant | — | +37.0K | 78.1K | +90% | — | |
| 2026-06-18 16:10 | 2026-06-17 | RXST | PALMISANO ROBERT J | Dir | A - Grant | — | +37.0K | 78.1K | +90% | — | |
| 2026-06-18 16:09 | 2026-06-17 | RXST | Maniar Shweta | Dir | A - Grant | — | +37.0K | 55.2K | +204% | — | |
| 2026-06-18 16:09 | 2026-06-17 | RXST | Fountain Tamara | Dir | A - Grant | — | +37.0K | 72.6K | +104% | — | |
| 2026-06-18 16:08 | 2026-06-17 | RXST | LINK WILLIAM J PHD | Dir | A - Grant | — | +37.0K | 74.9K | +98% | — | |
| 2026-06-18 16:08 | 2026-06-17 | RXST | Corley Jesse Anderson | Dir | A - Grant | — | +37.0K | 86.2K | +75% | — | |
| 2026-06-18 16:07 | 2026-06-17 | RXST | COHEN RAYMOND W | Dir | A - Grant | — | +30.9K | 66.5K | +87% | — | |
| 2026-06-18 16:06 | 2026-06-17 | RXST | Tammenoms Bakker Juliet | Dir | A - Grant | — | +37.0K | 85.2K | +77% | — | |
| 2026-06-18 16:06 | 2026-06-17 | RXST | Andrews Julie | Dir | A - Grant | — | +37.0K | 78.1K | +90% | — | |
| D | 2026-04-20 16:19 | 2026-04-17 | RXST | Goldshleger Ilya | COO | M - OptEx | $4.13 | +12.5K | 78.2K | +19% | +$51.6K |
| D | 2026-03-03 | 2026-02-28 | RXST | Wilterding Mark | CFO | M - OptEx | — | +20.4K | 20.4K | New | — |
| D | 2026-03-03 | 2026-02-28 | RXST | Wilterding Mark | CFO | F - Tax | $7.61 | -8,068 | 12.4K | -39% | -$61.4K |
| D | 2026-03-03 | 2026-02-28 | RXST | Gaines Scott | Chief Customer Off | F - Tax | $7.61 | -2,580 | 14.8K | -15% | -$19.6K |
| D | 2026-03-03 | 2026-02-28 | RXST | Gaines Scott | Chief Customer Off | M - OptEx | — | +6,261 | 17.4K | +56% | — |
| DM | 2025-09-26 | 2025-09-25 | RXST | Goldshleger Ilya | See remarks | M - OptEx | $4.27 | +23.4K | 57.3K | +69% | +$100.0K |
| 2025-08-04 | 2025-07-31 | RXST | COHEN RAYMOND W | Dir | A - Grant | $0.00 | +35.7K | 35.7K | New | $0 | |
| 2025-06-04 | 2025-06-03 | RXST | Maniar Shweta | Dir | A - Grant | — | +10.8K | 18.1K | +146% | — | |
| 2025-06-04 | 2025-06-03 | RXST | Fountain Tamara | Dir | A - Grant | — | +10.8K | 35.5K | +43% | — | |
| 2025-06-04 | 2025-06-03 | RXST | LINK WILLIAM J PHD | Dir | A - Grant | — | +10.8K | 37.9K | +40% | — | |
| 2025-06-04 | 2025-06-03 | RXST | Warner Robert Keith | Dir | A - Grant | — | +10.8K | 41.0K | +36% | — | |
| 2025-06-04 | 2025-06-03 | RXST | Tammenoms Bakker Juliet | Dir | A - Grant | — | +10.8K | 48.1K | +29% | — | |
| 2025-06-04 | 2025-06-03 | RXST | Andrews Julie | Dir | A - Grant | — | +10.8K | 41.0K | +36% | — | |
| 2025-06-04 | 2025-06-03 | RXST | Corley Jesse Anderson | Dir | A - Grant | — | +10.8K | 49.2K | +28% | — | |
| 2025-06-04 | 2025-06-03 | RXST | PALMISANO ROBERT J | Dir | A - Grant | — | +10.8K | 41.0K | +36% | — | |
| D | 2025-06-03 | 2025-06-02 | RXST | Weinberg Eric | See remarks | M - OptEx | $3.93 | +188.0K | 195.4K | +2,558% | +$738.8K |
| D | 2025-04-15 | 2025-04-14 | RXST | Thunen Shelley B | See remarks | M - OptEx | $4.34 | +7,792 | 38.4K | +25% | +$33.8K |
| T | 2025-03-13 | 2025-03-12 | RXST | Fountain Tamara | Dir | S - Sale | $25.71 | -7,000 | 24.8K | -22% | -$180.0K |
| T | 2025-01-27 | 2025-01-22 | RXST | Maniar Shweta | Dir | S - Sale | $30.87 | -3,519 | 7,383 | -32% | -$108.6K |
| MI | 2025-01-17 | 2025-01-15+ | RXST | Corley Jesse Anderson | Dir | P - Purchase | $31.16 | +3,210 | 1,443 | New | +$100.0K |
| DT | 2024-12-03 | 2024-11-29 | RXST | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +3,105 | 45.4K | +7% | +$46.8K |
| DT | 2024-12-03 | 2024-11-29 | RXST | Goldshleger Ilya | See remarks | S - Sale+OE | $46.08 | -3,105 | 42.2K | -7% | -$143.1K |
| DMT | 2024-11-26 | 2024-11-22+ | RXST | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +6,200 | 45.3K | +16% | +$93.5K |
| DMT | 2024-11-26 | 2024-11-22+ | RXST | Goldshleger Ilya | See remarks | S - Sale+OE | $45.44 | -6,200 | 42.2K | -13% | -$281.7K |
| T | 2024-11-26 | 2024-11-26 | RXST | Maniar Shweta | Dir | S - Sale | $45.88 | -3,782 | 10.9K | -26% | -$173.5K |
| DMT | 2024-11-18 | 2024-11-15+ | RXST | Goldshleger Ilya | See remarks | S - Sale+OE | $45.61 | -7,975 | 42.3K | -16% | -$363.8K |
| DMT | 2024-11-18 | 2024-11-15+ | RXST | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +7,975 | 45.3K | +21% | +$120.3K |
| DT | 2024-11-14 | 2024-11-12 | RXST | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +1,330 | 43.6K | +3% | +$20.1K |
| DT | 2024-11-14 | 2024-11-12 | RXST | Goldshleger Ilya | See remarks | S - Sale+OE | $46.13 | -1,330 | 42.2K | -3% | -$61.4K |
| MI | 2024-11-14 | 2024-11-12+ | RXST | Corley Jesse Anderson | Dir | P - Purchase | $45.25 | +16.7K | 468.6K | +4% | +$754.8K |
| M | 2024-11-14 | 2024-11-13 | RXST | Corley Jesse Anderson | Dir | P - Purchase | $44.84 | +5,795 | 36.7K | +19% | +$259.8K |
| DT | 2024-11-08 | 2024-11-07 | RXST | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +3,100 | 45.3K | +7% | +$46.7K |
| DMT | 2024-11-08 | 2024-11-07 | RXST | Goldshleger Ilya | See remarks | S - Sale+OE | $55.00 | -3,100 | 42.2K | -7% | -$170.5K |
| DMT | 2024-11-05 | 2024-11-04 | RXST | Goldshleger Ilya | See remarks | S - Sale+OE | $51.04 | -3,100 | 42.2K | -7% | -$158.2K |
| DT | 2024-11-05 | 2024-11-04 | RXST | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +3,100 | 45.3K | +7% | +$46.7K |
| DT | 2024-10-31 | 2024-10-30 | RXST | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +3,105 | 45.4K | +7% | +$46.8K |
| DT | 2024-10-31 | 2024-10-30 | RXST | Goldshleger Ilya | See remarks | S - Sale+OE | $51.91 | -3,105 | 42.2K | -7% | -$161.2K |
| DMT | 2024-10-28 | 2024-10-25+ | RXST | Goldshleger Ilya | See remarks | S - Sale+OE | $50.22 | -6,200 | 42.2K | -13% | -$311.3K |
| DMT | 2024-10-28 | 2024-10-25+ | RXST | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +6,200 | 45.3K | +16% | +$93.5K |
| DT | 2024-10-22 | 2024-10-22 | RXST | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +3,100 | 45.3K | +7% | +$46.7K |
| DT | 2024-10-22 | 2024-10-22 | RXST | Goldshleger Ilya | See remarks | S - Sale+OE | $49.68 | -3,100 | 42.2K | -7% | -$154.0K |
| DMT | 2024-10-18 | 2024-10-16+ | RXST | Goldshleger Ilya | See remarks | S - Sale+OE | $49.93 | -6,205 | 42.2K | -13% | -$309.8K |
| DMT | 2024-10-18 | 2024-10-16+ | RXST | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +6,205 | 45.3K | +16% | +$93.6K |
| DMT | 2024-10-15 | 2024-10-10+ | RXST | Goldshleger Ilya | See remarks | S - Sale+OE | $49.70 | -9,305 | 42.2K | -18% | -$462.5K |
| DMT | 2024-10-15 | 2024-10-10+ | RXST | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +9,305 | 45.4K | +26% | +$140.3K |
| DMT | 2024-10-08 | 2024-10-04+ | RXST | Goldshleger Ilya | See remarks | S - Sale+OE | $48.14 | -6,200 | 42.5K | -13% | -$298.4K |
| DMT | 2024-10-08 | 2024-10-04+ | RXST | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +6,200 | 45.3K | +16% | +$93.5K |
| DMT | 2024-10-02 | 2024-10-01 | RXST | Thunen Shelley B | See remarks | S - Sale+OE | $48.45 | -15.0K | 40.2K | -27% | -$726.8K |
| DT | 2024-10-02 | 2024-10-01 | RXST | Thunen Shelley B | See remarks | M - OptEx | $16.00 | +15.0K | 45.4K | +49% | +$240.0K |
| DMT | 2024-09-30 | 2024-09-26+ | RXST | Goldshleger Ilya | See remarks | S - Sale+OE | $49.15 | -6,205 | 43.7K | -12% | -$305.0K |
| DMT | 2024-09-30 | 2024-09-26+ | RXST | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +6,205 | 45.3K | +16% | +$93.6K |
| DMT | 2024-09-23 | 2024-09-20+ | RXST | Goldshleger Ilya | See remarks | S - Sale+OE | $52.93 | -6,200 | 42.4K | -13% | -$328.1K |
| DMT | 2024-09-23 | 2024-09-20+ | RXST | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +6,200 | 45.3K | +16% | +$93.5K |
| DT | 2024-09-18 | 2024-09-17 | RXST | Goldshleger Ilya | See remarks | S - Sale+OE | $56.11 | -3,100 | 42.2K | -7% | -$173.9K |
| DT | 2024-09-18 | 2024-09-17 | RXST | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +3,100 | 45.3K | +7% | +$46.7K |
| DM | 2024-08-09 | 2024-08-09 | RXST | Kurtz Ronald M MD | Pres, CEO, Dir | M - OptEx | $12.60 | +9,950 | 61.1K | +19% | +$125.3K |
| MT | 2024-08-06 | 2024-08-05 | RXST | Goldshleger Ilya | See remarks | S - Sale | $39.25 | -9,000 | 45.2K | -17% | -$353.3K |
| D | 2024-07-16 | 2024-07-15 | RXST | Thunen Shelley B | See remarks | M - OptEx | $4.34 | +16.5K | 30.4K | +118% | +$71.6K |
| D | 2024-07-12 | 2024-07-11 | RXST | Kurtz Ronald M MD | Pres, CEO, Dir | M - OptEx | $15.08 | +13.5K | 53.5K | +34% | +$203.6K |
| DMT | 2024-07-02 | 2024-07-01 | RXST | Thunen Shelley B | CFO | S - Sale+OE | $58.61 | -10.0K | 13.9K | -42% | -$586.1K |
| DMTI | 2024-07-02 | 2024-07-01 | RXST | Thunen Shelley B | CFO | S - Sale+OE | $58.77 | -8,402 | 0 | -100% | -$493.8K |
| DT | 2024-07-02 | 2024-07-01 | RXST | Thunen Shelley B | CFO | M - OptEx | $15.60 | +10.0K | 23.9K | +72% | +$156.0K |
| MT | 2024-06-17 | 2024-06-14 | RXST | Andrews Julie | Dir | S - Sale | $58.00 | -15.6K | 30.3K | -34% | -$906.3K |
| 2024-06-10 | 2024-06-06 | RXST | PALMISANO ROBERT J | Dir | A - Grant | — | +2,554 | 30.3K | +9% | — | |
| 2024-06-10 | 2024-06-06 | RXST | Corley Jesse Anderson | Dir | A - Grant | — | +2,554 | 32.6K | +8% | — | |
| 2024-06-10 | 2024-06-06 | RXST | Andrews Julie | Dir | A - Grant | — | +2,554 | 45.9K | +6% | — | |
| 2024-06-10 | 2024-06-06 | RXST | Maniar Shweta | Dir | A - Grant | — | +2,554 | 14.7K | +21% | — | |
| 2024-06-10 | 2024-06-06 | RXST | Tammenoms Bakker Juliet | Dir | A - Grant | — | +2,554 | 37.4K | +7% | — | |
| 2024-06-10 | 2024-06-06 | RXST | LINK WILLIAM J PHD | Dir | A - Grant | — | +2,554 | 27.1K | +10% | — | |
| 2024-06-10 | 2024-06-06 | RXST | Fountain Tamara | Dir | A - Grant | — | +2,554 | 31.8K | +9% | — | |
| 2024-06-10 | 2024-06-06 | RXST | Warner Robert Keith | Dir | A - Grant | — | +2,554 | 30.3K | +9% | — | |
| 2024-05-21 | 2024-05-17 | RXST | Tammenoms Bakker Juliet | Dir | P - Purchase | $61.09 | +5,000 | 34.8K | +17% | +$305.4K | |
| DM | 2024-05-20 | 2024-05-17 | RXST | Goldshleger Ilya | COO | M - OptEx | $4.04 | +24.8K | 42.1K | +143% | +$100.1K |
| TI | 2024-05-06 | 2024-05-03 | RXST | Kurtz Ronald M MD | Pres, CEO, Dir | S - Sale | $60.15 | -40.0K | 764.6K | -5% | -$2.41M |
| DT | 2024-05-02 | 2024-05-01 | RXST | Thunen Shelley B | CFO | M - OptEx | $15.60 | +10.2K | 23.9K | +75% | +$159.9K |
| DMT | 2024-05-02 | 2024-05-01 | RXST | Thunen Shelley B | CFO | S - Sale+OE | $52.69 | -10.0K | 13.9K | -42% | -$526.9K |
| MTI | 2024-04-02 | 2024-04-01 | RXST | Thunen Shelley B | CFO | S - Sale | $49.89 | -20.0K | 19.5K | -51% | -$997.9K |
| DT | 2024-03-05 | 2024-03-01 | RXST | Thunen Shelley B | CFO | M - OptEx | $15.60 | +10.0K | 23.7K | +73% | +$156.0K |
| DMT | 2024-03-05 | 2024-03-01 | RXST | Thunen Shelley B | CFO | S - Sale+OE | $56.37 | -10.0K | 13.7K | -42% | -$563.7K |
| DMT | 2024-02-16 | 2024-02-14+ | RXST | Goldshleger Ilya | COO | M - OptEx | $23.04 | +25.0K | 36.5K | +218% | +$576.0K |
| DMT | 2024-02-16 | 2024-02-14+ | RXST | Goldshleger Ilya | COO | S - Sale+OE | $54.00 | -25.0K | 31.5K | -44% | -$1.35M |
| M | 2024-02-15 | 2024-02-12+ | RXST | Tammenoms Bakker Juliet | Dir | P - Purchase | $50.84 | +8,000 | 25.8K | +45% | +$406.7K |
Purchase Sale Sale after option exercise All abbreviations